Trial intelligence / Profile preview

Dexmedetomidine as Adjuvant in Scalp Block for Craniotomy

NCT06951256Completed

Sponsor
Ain Shams University
Start
Mar 2024
Primary completion
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in craniotomy (2 arms), sponsored by Ain Shams University. Primary endpoint: Intraoperative Mean Arterial Pressure. Started Mar 2024; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

craniotomy

Beyond the preview

Go deeper on NCT06951256.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06951256.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call